Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Short-term Investments (2019 - 2025)

Burning Rock Biotech has reported Short-term Investments over the past 7 years, most recently at $380116.1 for Q4 2025.

  • For Q4 2025, Short-term Investments rose 18.05% year-over-year to $380116.1; the TTM value through Dec 2025 reached $380116.1, up 18.05%, while the annual FY2025 figure was $386000.0, 21.77% up from the prior year.
  • Short-term Investments for Q4 2025 was $380116.1 at Burning Rock Biotech, down from $419000.0 in the prior quarter.
  • Over five years, Short-term Investments peaked at $10.0 million in Q1 2022 and troughed at $8000.0 in Q1 2024.
  • A 5-year average of $1.7 million and a median of $380116.1 in 2025 define the central range for Short-term Investments.
  • Biggest five-year swings in Short-term Investments: soared 12600.0% in 2021 and later tumbled 99.43% in 2024.
  • Year by year, Short-term Investments stood at $1.2 million in 2021, then skyrocketed by 128.54% to $2.8 million in 2022, then plummeted by 99.4% to $16666.5 in 2023, then soared by 1832.06% to $322006.0 in 2024, then rose by 18.05% to $380116.1 in 2025.
  • Business Quant data shows Short-term Investments for BNR at $380116.1 in Q4 2025, $419000.0 in Q3 2025, and $321000.0 in Q2 2025.